NCT07112053 2026-03-09
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
University of Washington
Phase 2 Recruiting
Clinical Trials
4 trialsNCT07407920 2026-02-12
Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04019834 2022-08-03
RELIEF
University of Alabama at Birmingham
Phase EARLY_PHASE1 Completed
NCT04640220 2022-01-10
Improvement of Range of Motion in Frozen Shoulder in Breast Cancer Survivors
Yeungnam University Hospital
Phase NA Completed